RVPH - Balance Sheet - Reviva Pharmaceuticals Holdings, Inc.

Current Liabilities	17.2 M
Accounts Payable	3.85 M
Short-Term Debt	0
Other Current Liabilities	13.3 M
Non-Current Liabilities	807 K
Long-Term Debt	0
Other Non-Current Liabilities	807 K

Millions

	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Feb-2020	Feb-2019
ASSETS
Cash & Cash Equivalents	23.4	18.5	29.7	8.8	193	0
Short Term Investments	0	0	0	0	65.2	65.2
Receivables	0	0	0	0	0	0
Inventory	0	0	0	0	0	0
Other Current Assets	0.3	0.4	1.7	69.6 K	0	0
Total Current Assets	23.7	18.9	31.4	8.8	193	65.2
PP&E	0	0	0	0	591	0
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0
Other Long Term Assets	0	0	0	1.82 K	1.82 K	0
Other Assets	0	0.4	1.7	0	0	0
Total Assets	23.7	18.9	31.4	8.8	2.6 K	65.2
LIABILITIES
Accounts Payable	3.8	3.5	0.5	1.0	0.2	0
Short Term Debt	0	0	0	0	3.8	0
Other Current Liabilities	13.3	(1.0)	1.3	(0.7)	(0.1)	0
Total Current Liabilities	17.2	6.0	2.3	1.3	6.8	0
Long Term Debt	0	0	0	0	0	0
Deferred Tax Income	0	0	0	0	0	0
Other Liabilities	0.8	0.6	0.4	3.0	0	0
Total Liabilities	18.0	6.6	2.7	1.3	6.8	6.1
EQUITY
Common Stock	2.79 K	2.04 K	1.44 K	923	618	0
Retained Earnings	(134.4)	(91.2)	(66.8)	(58.3)	(54.5)	0
Other Accumulative Comprehensive Income/Loss	0	0	0	0	(54.5)	0
Total Equity	5.7	12.3	28.7	7.4	(6.8)	0
Total Liabilities and Equity	23.7	18.9	31.4	8.8	2.6 K	65.2
SHARES OUTSTANDING
Common Shares Outstanding	23.8	19.5	14.8	3.1	2.8	0

Free